Advancing treatment strategies for prostate cancer patients
Official title: University of Wisconsin Prostate SPORE
Funded at University of Wisconsin-Madison · NIH-10899409 · Data updated 2026-11-12
This study at the University of Wisconsin is all about finding better treatments for prostate cancer by bringing together scientists and doctors to work on new ideas that can help patients, including looking at how tumors behave and developing therapies that boost the immune system.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,085,688 |
| NIH project number | 5P50CA269011-02 |
| Project ID | NIH-10899409 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with advanced prostate cancer, particularly those facing treatment resistance.
✕Less likely to help
Patients with early-stage prostate cancer or those not diagnosed with prostate cancer may not benefit from this research.
What this research studies
The University of Wisconsin Prostate SPORE focuses on improving treatment for prostate cancer by connecting basic scientists with clinicians. This collaborative effort aims to enhance multidisciplinary research, develop new resources, and translate innovative approaches directly to patients. Key projects include studying tumor microenvironments, exploring immune-modulating therapies, and targeting resistant cancer lesions. The initiative also emphasizes training the next generation of prostate cancer researchers.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and quality of life for prostate cancer patients.
How similar studies have gone: Previous research has shown promise in similar collaborative approaches to cancer treatment, indicating potential for success in this initiative.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Jarrard, David F. — University of Wisconsin-Madison
- Study coordinator: Jarrard, David F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.